Skip to main content
Erschienen in: International Urogynecology Journal 7/2014

01.07.2014 | Original Article

Clinical and urodynamic evaluation of women referred with diabetes mellitus

verfasst von: He Changxiao, Yuan Zhengyong, Yan Shibing, Wu Caiwen, Huang Yingchuan, He Wei, Wang Hanhui, Li Dong, Huang Peng, Lei Jing, Zhou Rui, Liao Jia, Shen Hong

Erschienen in: International Urogynecology Journal | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

We investigated the impact of diabetes mellitus (DM) on female lower urinary tract dysfunction.

Methods

We prospectively collected data of 1,640 consecutive diabetic women from the inpatient departments and outpatient clinics of urology, endocrinology, geriatrics, and nephrology in primary, secondary, and tertiary referral hospitals, rural healthcare stations, and nursing homes in Dujiangyan, China. Clinical histories were taken on an individualized basis depending on patient presentation. Urodynamics were performed in the enrolled female diabetic patients after excluding other causes of lower urinary tract dysfunction. Data on lower urinary tract symptoms and urodynamic parameters were analyzed.

Results

Ninety-three percent of diabetic women complained of lower urinary tract symptoms, and 88 % had positive urodynamic findings. Sixty-three percent presented with storage symptoms, 918 cases of which had detrusor overactivity, 787 impaired detrusor contractility, and 131 detrusor areflexia. Among the 918 patients with impaired detrusor contractility or detrusor areflexia, the mean first sensation of filling was 238.1 ml, with a mean maximum cystometric capacity of 624 ml, mean maximum flow rate of 9.6 ml/s, mean detrusor pressure at maximum flow rate of 32.4 cmH2O, and mean postvoid residual of 323 ml. Thirty-eight of 131 patients with detrusor areflexia had impaired renal function on blood chemistry test, and massive bilateral ureterohydronephrosis and “Christmas-tree-shaped” bladder in videourodynamic studies. On the whole, 95 % diabetic women had diabetic cystopathy.

Conclusions

DM alters voiding patterns significantly, causing various lower urinary tract symptoms in a significant proportion of diabetic women. Diabetic cystopathy is a progressive condition with a spectrum of clinical symptoms and urodynamic findings. The prevalence of diabetic cystopathy is very high in Dujiangyan, China.
Literatur
1.
Zurück zum Zitat Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention
2.
Zurück zum Zitat Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G, 2010 China Noncommunicable Disease Surveillance Group (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948–959PubMedCrossRef Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G, 2010 China Noncommunicable Disease Surveillance Group (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948–959PubMedCrossRef
3.
Zurück zum Zitat Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21(1):5–26PubMedCrossRef Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21(1):5–26PubMedCrossRef
4.
Zurück zum Zitat Kaplan SA, Te AE, Blaivas JG (1995) Urodynamic findings in patients with diabetic cystopathy. J Urol 153(2):342–344PubMedCrossRef Kaplan SA, Te AE, Blaivas JG (1995) Urodynamic findings in patients with diabetic cystopathy. J Urol 153(2):342–344PubMedCrossRef
5.
Zurück zum Zitat Sasaki K, Yoshimura N, Chancellor MB (2003) Implications of diabetes mellitus in urology. Urol Clin N Am 30(1):1–12CrossRef Sasaki K, Yoshimura N, Chancellor MB (2003) Implications of diabetes mellitus in urology. Urol Clin N Am 30(1):1–12CrossRef
6.
Zurück zum Zitat Fayyad AM, Hill SR, Jones GR (2009) Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic. Int Urogynecol J Pelvic Floor Dysfunct 20:1339–1344PubMedCrossRef Fayyad AM, Hill SR, Jones GR (2009) Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic. Int Urogynecol J Pelvic Floor Dysfunct 20:1339–1344PubMedCrossRef
7.
Zurück zum Zitat Moller CF, Olesen KP (1976) Diabetic cystopathy IV: Micturition cystourethrography compared with urodynamic investigation. Dan Med Bull 23:291PubMed Moller CF, Olesen KP (1976) Diabetic cystopathy IV: Micturition cystourethrography compared with urodynamic investigation. Dan Med Bull 23:291PubMed
8.
Zurück zum Zitat Moller CF (1976) Diabetic cystopathy III: Urinary bladder dysfunction in relation to bacteriuria. Dan Med Bull 23:287PubMed Moller CF (1976) Diabetic cystopathy III: Urinary bladder dysfunction in relation to bacteriuria. Dan Med Bull 23:287PubMed
9.
Zurück zum Zitat Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ (2004) Effects of diabetes on female voiding behavior. J Urol 172:989–992PubMedCrossRef Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ (2004) Effects of diabetes on female voiding behavior. J Urol 172:989–992PubMedCrossRef
10.
Zurück zum Zitat Liu RT, Chung MS, Lee WC, Chang SW, Huang ST, Yang KD et al (2011) Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology 78:1040–1045PubMedCrossRef Liu RT, Chung MS, Lee WC, Chang SW, Huang ST, Yang KD et al (2011) Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology 78:1040–1045PubMedCrossRef
11.
Zurück zum Zitat Lee WC (2009) The Impact of Diabetes on the Lower Urinary Tract Dysfunction. JTUA 20:155–161 Lee WC (2009) The Impact of Diabetes on the Lower Urinary Tract Dysfunction. JTUA 20:155–161
12.
13.
Zurück zum Zitat Pannek J, Blok B, Castro-Diaz D, Del Popolo G, Kramer G, Radziszewski P, Reitz A, Stöhrer M, Wyndaele J-J (2013) Guidelines on Neurogenic Lower Urinary Tract Dysfunction. European Association of Urology 10 Pannek J, Blok B, Castro-Diaz D, Del Popolo G, Kramer G, Radziszewski P, Reitz A, Stöhrer M, Wyndaele J-J (2013) Guidelines on Neurogenic Lower Urinary Tract Dysfunction. European Association of Urology 10
14.
Zurück zum Zitat Yoshimura N, Chancellor MB, Andersson KE, Christ GJ (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95:733–738PubMedCrossRef Yoshimura N, Chancellor MB, Andersson KE, Christ GJ (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95:733–738PubMedCrossRef
15.
Zurück zum Zitat Beshay E, Carrier S (2004) Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model. Urology 64(5):1062PubMedCrossRef Beshay E, Carrier S (2004) Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model. Urology 64(5):1062PubMedCrossRef
16.
Zurück zum Zitat Ueda T, Yoshimura N, Yoshida O (1997) Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 157:580–584PubMedCrossRef Ueda T, Yoshimura N, Yoshida O (1997) Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 157:580–584PubMedCrossRef
17.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Flowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef Knowler WC, Barrett-Connor E, Flowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef
18.
Zurück zum Zitat Subak LL, Johnson C, Whitcomb E, Boban D, Saxton J, Brown JS (2002) Does weight loss improve incontinence in moderately obese women? Int Urogynecol J Pelvic Floor Dysfunct 13:40–43PubMedCrossRef Subak LL, Johnson C, Whitcomb E, Boban D, Saxton J, Brown JS (2002) Does weight loss improve incontinence in moderately obese women? Int Urogynecol J Pelvic Floor Dysfunct 13:40–43PubMedCrossRef
19.
Zurück zum Zitat Brown JS, Wing R, Barrett-Connor E, Nyberg LM, Kusek JW, Orchard TJ, Ma Y, Vittinghoff E, Knaya AM, Diabetes Prevention Program Research Group (2006) Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care 29:385–390PubMedCentralPubMedCrossRef Brown JS, Wing R, Barrett-Connor E, Nyberg LM, Kusek JW, Orchard TJ, Ma Y, Vittinghoff E, Knaya AM, Diabetes Prevention Program Research Group (2006) Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care 29:385–390PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Chapple C, Khulla V, Gabriel Z, Dooley JA (2005) The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 48:5–26PubMedCrossRef Chapple C, Khulla V, Gabriel Z, Dooley JA (2005) The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 48:5–26PubMedCrossRef
21.
Zurück zum Zitat Novara G, Galfano A, Secco S, D’Elia C, Cavalleri S, Ficarra V, Artibani W (2008) A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 54:740–763PubMedCrossRef Novara G, Galfano A, Secco S, D’Elia C, Cavalleri S, Ficarra V, Artibani W (2008) A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 54:740–763PubMedCrossRef
22.
Zurück zum Zitat Zincke H, Campbell JT, Palumbo PJ, Furlow WL (1974) Neurogenic vesical dysfunction in diabetes mellitus: another look at vesical neck Resection. J Urol 111:488–490PubMed Zincke H, Campbell JT, Palumbo PJ, Furlow WL (1974) Neurogenic vesical dysfunction in diabetes mellitus: another look at vesical neck Resection. J Urol 111:488–490PubMed
23.
Zurück zum Zitat Fedele D (2005) Therapy insight: sexual and bladder dysfunction associated with diabetes mellitus. Nat Clin Pract Urol 2:282–290PubMedCrossRef Fedele D (2005) Therapy insight: sexual and bladder dysfunction associated with diabetes mellitus. Nat Clin Pract Urol 2:282–290PubMedCrossRef
24.
Zurück zum Zitat Daniels DH, Powell CR, Braasch MR, Kreder KJ (2010) Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction. Neurourol Urodyn 29:578–581PubMed Daniels DH, Powell CR, Braasch MR, Kreder KJ (2010) Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction. Neurourol Urodyn 29:578–581PubMed
25.
Zurück zum Zitat Van Kerrebroeck PE, Van Voskuilen AC, Heesakkers JP et al (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178:2029–2034PubMedCrossRef Van Kerrebroeck PE, Van Voskuilen AC, Heesakkers JP et al (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178:2029–2034PubMedCrossRef
Metadaten
Titel
Clinical and urodynamic evaluation of women referred with diabetes mellitus
verfasst von
He Changxiao
Yuan Zhengyong
Yan Shibing
Wu Caiwen
Huang Yingchuan
He Wei
Wang Hanhui
Li Dong
Huang Peng
Lei Jing
Zhou Rui
Liao Jia
Shen Hong
Publikationsdatum
01.07.2014
Verlag
Springer London
Erschienen in
International Urogynecology Journal / Ausgabe 7/2014
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-014-2354-5

Weitere Artikel der Ausgabe 7/2014

International Urogynecology Journal 7/2014 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.